| Name | Title | Contact Details |
|---|
Haven Health Ctr At Seacoast is a Hampton, NH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Blue Spring International is a Oklahoma City, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Holy Family Manor Inc is a Orwigsburg, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
For more than 100 years, VNA Health Group`s visiting nurses of NJ have made a difference in people`s lives Compassionate, caring, patient-centered, home- and community-based care delivered to you by people who take the time to know you, not just your medical history. We bring advanced care to where you`re most comfortable and can heal the fastest— in your home or wherever you reside. Each year, as the largest, non-profit visiting nurse association in New Jersey, our inter-disciplinary team provide services to more than 120,000 of your neighbors and friends, perhaps even you or someone you love. We are proud to know that we help make our community a healthier place. Whether it`s providing care for children with special needs or in-home care for seniors, we can help.
Immune Pharmaceuticals applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. The Company’s lead product candidate, bertilimumab, is entering Phase II clinical studies for moderate-to-severe ulcerative colitis and bullous pemphigoid, with additional studies planned for Crohn’s disease and severe asthma. The Company is evaluating the use of its NanomAb® platform, a second generation antibody drug conjugate technology, with chemotherapeutics in order to enhance their safety and efficacy profiles by delivering the medicines directly to cancer cells. The Company’s growing oncology pipeline also includes proprietary antibodies and, clinical-stage small molecules that have been shown activity in a variety of solid tumors. Immune is headquartered in the U.S., with its primary research and development facilities in Israel.